NDC codes

FDA NDC Directory
Product NDC (as listed)71335-0414Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71335-0414Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71335-0414-17133504140160 TABLET in 1 BOTTLE (71335-0414-1)Marketed from May 13, 2020
71335-0414-271335041402120 TABLET in 1 BOTTLE (71335-0414-2)Marketed from Oct 5, 2021
71335-0414-37133504140390 TABLET in 1 BOTTLE (71335-0414-3)Marketed from Oct 9, 2018
71335-0414-47133504140430 TABLET in 1 BOTTLE (71335-0414-4)Marketed from Sep 17, 2018
71335-0414-57133504140528 TABLET in 1 BOTTLE (71335-0414-5)Marketed from Oct 30, 2024
71335-0414-67133504140618 TABLET in 1 BOTTLE (71335-0414-6)Marketed from Oct 30, 2024
71335-0414-77133504140745 TABLET in 1 BOTTLE (71335-0414-7)Marketed from Oct 30, 2024
71335-0414-871335041408100 TABLET in 1 BOTTLE (71335-0414-8)Marketed from Oct 30, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
NP Thyroid 60
Generic name (nonproprietary)
levothyroxine, liothyronine
Active ingredients
Levothyroxine — 38 ug/1Liothyronine — 9 ug/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
Unapproved drug (other)
Marketing start
Listing expires
Other FDA classes
Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
Identifiers
Product ID 71335-0414_d21e2854-05ff-4b35-9dbf-e08a32b3463fSPL ID d21e2854-05ff-4b35-9dbf-e08a32b3463fSPL set ID cc422f98-2b6d-4cbf-9eab-2a391fb83219RxCUI 313391, 1724481UNII Q51BO43MG4, 06LU7C9H1V
Pharmacologic class
l-Thyroxine; l-Triiodothyronine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335041401 followed by a unit qualifier and the quantity

Package 71335-0414-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE: NP Thyroid® tablets (thyroid tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WA…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in